(Q35637406)

9 August 2017

Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations (English)

1 reference

9 August 2017

1 reference

P M Aries

1

1 reference

9 August 2017

B Hellmich

2

1 reference

9 August 2017

J Voswinkel

3

1 reference

9 August 2017

M Both

4

1 reference

9 August 2017

B Nölle

5

1 reference

9 August 2017

K Holl-Ulrich

6

1 reference

9 August 2017

P Lamprecht

7

1 reference

9 August 2017

W L Gross

8

1 reference

9 August 2017

language of work or name

English

0 references

publication date

3 November 2005

1 reference

Annals of the Rheumatic Diseases

9 August 2017

1 reference

9 August 2017

65

1 reference

9 August 2017

7

1 reference

9 August 2017

853-858

1 reference

Orbital socket contracture: a complication of inflammatory orbital disease in patients with Wegener's granulomatosis

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

The role of long-lived plasma cells in autoimmunity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Lifetime of plasma cells in the bone marrow.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Plasma cells for a lifetime?

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798224

Development and validation of a disease extent index for Wegener's granulomatosis

25 September 2018

1 reference

12 December 2020

High-dose intravenous azathioprine pulse treatment in refractory Wegener's granulomatosis

1 reference

12 December 2020

Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment?

1 reference

12 December 2020

Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin

1 reference

12 December 2020

Humoral immunity due to long-lived plasma cells.

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2005.044420

1 reference

9 August 2017

1 reference

9 August 2017

1 reference